https://pubmed.ncbi.nlm.nih.gov/24347795/
Circulating autoantibodies to LGALS3BP: a novel biomarker for cancer
Anti-LGALS3BP IgG autoantibodies are a promising biomarker for malignant tumors and could play a role in the development of a multimarker assay for the early...
a novelcirculatingautoantibodiesbiomarkercancer